Registered Zambia · ZAMRA

Lebasma-4 tablets

Salbactum Sodium 4 mg

149/029 Tablet Uncoated 4 mg

What it does

Salbactum is a medicine that helps fight infections caused by bacteria.

Commonly used for: bacterial infections, infections in patients with weakened immune systems

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
149/029
Registration date
2025-08-15
Expiry date
2030-08-14
Status
Registered/Compliant
Active ingredient
Salbactum Sodium 4 mg
Dosage form
Tablet Uncoated
Strength
4 mg
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Leben Laboratories
Country of origin
India
Manufacturer location
M3P7+C4H, Midc Phase 3 and 4, MIDC, Shivar, Maharashtra 444104, India

Source: Zambia Medicines Regulatory Authority · fetched 2026-03-12 00:00:52 · updated 2026-09-24 03:32:20

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About this medicine

Salbactum is a medicine that helps fight infections caused by bacteria.

What it treats

  • bacterial infections
  • infections in patients with weakened immune systems

How it works

Salbactum works by stopping bacteria from growing and multiplying, helping the body to fight off infections.

Who it's for

This medicine is for adults and children who have certain types of bacterial infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: salbactum

Salbactum is a beta-lactamase inhibitor that is primarily used in combination with beta-lactam antibiotics to enhance their efficacy against resistant bacterial strains. It prevents the breakdown of beta-lactam antibiotics by certain bacterial enzymes, thereby extending their spectrum of activity. Salbactum is particularly effective against gram-negative bacteria that produce beta-lactamase, making it a valuable component in the treatment of various bacterial infections.

Indications

  • Complicated urinary tract infections
  • Intra-abdominal infections
  • Skin and soft tissue infections
  • Pneumonia caused by susceptible strains
  • Sepsis from beta-lactamase producing organisms

Dosage

Children: Refer to the BNF for Children for appropriate dosing based on age

Adults: Refer to specific guidelines for dosing based on the combination with the beta-lactam antibiotic being used. Dosing should consider the severity of the infection and renal function.

Mechanism of action

Salbactum works by irreversibly binding to and inhibiting the activity of beta-lactamase enzymes produced by certain bacteria. This inhibition prevents the hydrolysis of the beta-lactam ring of antibiotics, enabling these drugs to remain effective against bacteria that would otherwise be resistant due to the action of these enzymes. The presence of salbactum allows for sustained antimicrobial activity of the co-administered antibiotics, enhancing their therapeutic effectiveness.

Pharmacodynamics

Salbactum exhibits a synergistic effect when used in conjunction with beta-lactam antibiotics. It enhances the antibacterial spectrum of these antibiotics, particularly against penicillin-resistant strains. The combination therapy can lead to improved clinical outcomes and reduction in treatment failures associated with resistant infections. The pharmacodynamic profile is characterized by bactericidal activity, where the drug combination leads to the death of bacteria, particularly in rapidly dividing organisms.

Pharmacokinetics

The pharmacokinetics of salbactum, when administered with beta-lactam antibiotics, may vary based on the specific antibiotic used. Generally, salbactum is administered parenterally, with good tissue penetration observed. It is metabolized in the liver and excreted primarily through the kidneys. The half-life can range depending on the formulation and the concomitant antibiotics, necessitating careful consideration of dosing intervals to maintain effective plasma concentrations.

Adverse effects

  • Hypersensitivity reactions
  • Nausea
  • Vomiting
  • Diarrhea
  • Rash
  • Fever

Precautions

  • Use with caution in patients with a history of allergies
  • Monitor renal function in patients with renal impairment
  • Consider potential interaction with other antibiotics

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised as it is not known if salbactum is excreted in human milk.

Storage

Store in a cool, dry place away from direct light. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.